Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Therapeutics Inc (OTCQB:BTHE)

0.0751
Delayed Data
As of Dec 02
 -0.0149 / -16.56%
Today’s Change
0.03
Today|||52-Week Range
0.17
-31.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$3.4M

Company Description

Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products include therapeutic modules such as BTI320, Ipoxyn, and Oxyfex. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Newton, MA.

Contact Information

Boston Therapeutics, Inc.
233 Needham Street
Newton Massachusetts 02464
P:(603) 935-9799
Investor Relations:

Employees

Shareholders

Individual stakeholders36.87%
Mutual fund holders--
Other institutional--

Top Executives

Carl W. RauschChief Executive Officer
Stephen A. SpanosChief Financial Officer
Benjamin RivnayChief Scientist